Virtual Pharma Marathon: Kazakhstan’s pharmaceutical market during the global pandemic

Last week Oleg Kurilov, General Director of GCT in Kazakhstan took part at the Virtual Pharmaceutical Marathon. The event was dedicated to the pharmaceutical market in Kazakhstan. It focused on the industry strategies during the COVID-19 Pandemic. The topics included interaction with the Regulatory Authority, pharmacy and patients as well as price regulation and development of digital promotion channels.

In January 2020, GCT expanded its operations to Kazakhstan. The country is located in Central Asia and is part of The Eurasian Economic Union (EAEU). Kazakhstan is now actively preparing to transition to registering drugs according to the EAEU rules in 2021. It is an attractive for clinical research and a rapidly developing region. Conducting clinical trials in Kazakhstan is cost effective and offers high standards of quality with adherence to ICH GCP.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.